Promoting Competition
and Investment in the
U.S. Life Sciences Ecosystem

The U.S. life sciences ecosystem depends on mergers and acquisitions (M&A) to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients.

DRIVING THE INNOVATION ECOSYSTEM
M&A fuels innovation across a diverse and dynamic life sciences ecosystem.
LEVERAGING EFFICIENCY AND EXPERTISE
M&A drives efficiency and expertise across the life sciences industry, expediting the process of bringing new treatments and cures to market.
PRESERVING AMERICAN LEADERSHIP
M&A is a core component of the unique and world-class American life sciences ecosystem.

U.S. biopharmaceutical companies with establishments in every state

invested in R&D by top 15 biopharmaceutical companies

of biopharmaceutical companies operate without a profit

PARTNERS

ABOUT US

PULSE is dedicated to raising awareness about the vital role of mergers and acquisitions (M&A) as well as other collaborations to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients. Our members represent frontline researchers, employees and leaders of life sciences companies of all sizes that support a diverse, vibrant life sciences ecosystem at the national level and in local communities. PULSE will help advance a national dialogue focused on fostering innovation across the life sciences while supporting a competitive U.S. market that delivers next generation treatments and cures
for patients.

LATEST NEWS

Opinion: Beware of new regs

How mergers and acquisitions drive innovative cures and New Jersey’s economy New Jersey has long been home to some of the world’s leading research-based biopharmaceutical companies. Many have made New Jersey a base for their global, North American, or U.S. operations....

read more